Differential expression and processing of matrix metalloproteinase 19 marks progression of gastrointestinal diseases
Language English Country Czech Republic Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
25056434
DOI
10.14712/fb2014060030113
PII: file/5723/fb2014a0015.pdf
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Gastrointestinal Diseases enzymology pathology MeSH
- HCT116 Cells MeSH
- Colon enzymology pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Matrix Metalloproteinases, Secreted metabolism MeSH
- Young Adult MeSH
- Protein Processing, Post-Translational * MeSH
- Disease Progression * MeSH
- Antibodies metabolism MeSH
- Reproducibility of Results MeSH
- Aged MeSH
- Intestinal Mucosa enzymology pathology MeSH
- Intestine, Small enzymology pathology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- matrix metalloproteinase 19 MeSH Browser
- Matrix Metalloproteinases, Secreted MeSH
- Antibodies MeSH
Matrix metalloproteinases (MMPs), responsible for extracellular matrix remodelling and processing of numerous soluble and cell-surface proteins, appear to play important roles in pathogenesis of gastrointestinal diseases. MMPs influence migration of inflammatory cells, mucosal destruction, matrix deposition and degradation. In this study, we analysed the expression of MMP-19 in the main forms of gastrointestinal diseases including inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease, and colorectal carcinoma. We identified prominent MMP-19 expression in unaffected areas of intestinal epithelia and macrophages but not in other cells or tissues. Abundant expression of MMP-19 was also found in the endothelium of blood and lymphatic vessels of inflamed intestinal tissue. High MMP-19 immunoreactivity was also associated with macrophages in inflamed areas and myenteric plexuses. In comparison to the intestinal epithelium, all these cell types and compartments appeared to express MMP-19 irrespective of the disease pathogenesis and progression. Intestinal epithelia exhibited striking differential immunoreactivity for MMP-19. While immunoreactivity of monoclonal antibody recognizing the propeptide domain declined in virtually all IBD and colorectal carcinoma samples, other polyclonal antibodies against the hinge region and propetide domain did not show such an obvious decrease. Additional Western blotting analysis revealed that the antibodies against MMP-19 recognize differently processed forms of this MMP. The disappearance of immunoreactivity of the monoclonal anti-propeptide domain antibody does not mean down-regulation of MMP-19, but processing of the immature form. As this processing likely leads to the activation of this MMP, the differential staining pattern may be an important sign of disease progression.
Department of Pathology and Molecular Medicine Thomayer Hospital Prague Czech Republic
Gastroenterology Surgical Centre Hospital of Merciful Sisters of St Borromeo Prague Czech Republic
References provided by Crossref.org
MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function